Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate severe atopic dermatitis

被引:0
|
作者
Cho, Yung-Tsu [1 ,2 ]
Lee, Meng-Sui [3 ,4 ]
Chang, Wen -Yu [5 ,6 ]
Lu, Yea-Ting [1 ,2 ]
Chu, Chia -Yu [1 ,2 ]
Chan, Tom C. [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100225, Taiwan
[2] Natl Taiwan Univ, Coll Med, 7 Chung Shan South Rd, Taipei 100225, Taiwan
[3] Taipei City Hosp, Dept Dermatol, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Dept Dermatol, Taipei, Taiwan
[5] I Shou Univ, E Da Canc Hosp, Dept Dermatol, Kaohsiung, Taiwan
[6] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung, Taiwan
来源
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2024年 / 12卷 / 07期
关键词
D O I
10.1016/j.jaip.2024.04.008
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1924 / 1927.e1
页数:5
相关论文
共 50 条
  • [21] Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis
    Egídio Freitas
    Maria João Paiva Lopes
    Maria João Cruz
    Diogo Sousa
    Ana Clara Valente
    Bruno Duarte
    Laetitia Teixeira
    Gilberto Rosas
    Mónica Caetano
    Alberto Mota
    Paulo Filipe
    Tiago Torres
    Clinical Drug Investigation, 2024, 44 : 87 - 90
  • [22] Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
    Sheridan M. Hoy
    American Journal of Clinical Dermatology, 2022, 23 : 409 - 420
  • [23] Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis
    Freitas, Egidio
    Lopes, Maria Joao Paiva
    Cruz, Maria Joao
    Sousa, Diogo
    Valente, Ana Clara
    Duarte, Bruno
    Teixeira, Laetitia
    Rosas, Gilberto
    Caetano, Monica
    Mota, Alberto
    Filipe, Paulo
    Torres, Tiago
    CLINICAL DRUG INVESTIGATION, 2024, 44 (01) : 87 - 90
  • [24] Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
    Hoy, Sheridan M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 409 - 420
  • [25] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [26] TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis
    Weidinger, S.
    Stoelzl, D.
    Abraham, S.
    Haufe, E.
    Heratizadeh, A.
    Werfel, T.
    Schmitt, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S236 - S236
  • [27] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    Marjolein S. de Bruin-Weller
    Esther Serra-Baldrich
    Sebastien Barbarot
    Susanne Grond
    Christopher Schuster
    Helmut Petto
    Jean-Philippe Capron
    Afaf Raibouaa
    Thomas Werfel
    Dermatology and Therapy, 2022, 12 : 1481 - 1491
  • [28] Real-world persistence with dupilumab among adults with atopic dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Gadkari, Abhijit
    Kuznik, Andreas
    Mallya, Usha G.
    Mastey, Vera
    Zhang, Haixin
    Chen, Zhen
    Chen, Cheng
    Korotzer, Andrew
    Sierka, Debra
    Fenton, Miriam C.
    Kaur, Mandeep
    Jalbert, Jessica J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 40 - 45
  • [29] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [30] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
    de Bruin-Weller, Marjolein S.
    Serra-Baldrich, Esther
    Barbarot, Sebastien
    Grond, Susanne
    Schuster, Christopher
    Petto, Helmut
    Capron, Jean-Philippe
    Raibouaa, Afaf
    Werfel, Thomas
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1481 - 1491